Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (487K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Czauderna, F.
Right arrow Articles by Kaufmann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Czauderna, F.
Right arrow Articles by Kaufmann, J.
Related Collections
Right arrow Monitoring gene expression
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2003, Vol. 31, No. 2 670-682
© 2003 Oxford University Press

Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA

Frank Czauderna, Melanie Fechtner, Hüseyin Aygün1, Wolfgang Arnold, Anke Klippel, Klaus Giese and Jörg Kaufmann*

Atugen AG, Otto Warburg Haus (Nr. 80), Robert-Roessle-Strasse 10, 13125 Berlin, Germany and 1 BioSpring, Hanauer Landstrasse 526, 60386 Frankfurt, Germany

*To whom correspondence should be addressed. Tel: +49 30 9489 2833; Fax: +49 30 9489 2801; Email: kaufmann{at}atugen.com

RNA interference (RNAi) is a RNA-mediated sequence-specific gene silencing mechanism. Recently, this mechanism has been used to down-regulate protein expression in mammalian cells by applying synthetic- or vector-generated small interfering RNAs (siRNAs). However, for the evaluation of this new knockdown technology, it is crucial to demonstrate biological consequences beyond protein level reduction. Here, we demonstrate that this new siRNA-based technology is suitable to analyse protein functions using the phosphatidylinositol (PI) 3-kinase signal transduction pathway as a model system. We demonstrate stable and transient siRNA-mediated knockdown of one of the PI 3-kinase catalytic subunits, p110ß, which leads to inhibition of invasive cell growth in vitro as well as in a tumour model system. Importantly, this result is consistent with loss-of-function phenotypes induced by conventional RNase H-dependent antisense molecules or treatment with the PI 3-kinase inhibitor LY294002. RNAi knockdown of the downstream kinases Akt1 and Akt2 does not reduce cell growth on extracellular matrix. Our data show that synthetic siRNAs, as well as vector-based expression of siRNAs, are a powerful new tool to interfere with signal transduction processes for the elucidation of gene function in mammalian cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
R. J. Crowder, C. Phommaly, Y. Tao, J. Hoog, J. Luo, C. M. Perou, J. S. Parker, M. A. Miller, D. G. Huntsman, L. Lin, et al.
PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer
Cancer Res., May 1, 2009; 69(9): 3955 - 3962.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Zollinger, T. Stuhmer, M. Chatterjee, S. Gattenlohner, E. Haralambieva, H.-K. Muller-Hermelink, M. Andrulis, A. Greiner, C. Wesemeier, J. C. Rath, et al.
Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma
Blood, October 15, 2008; 112(8): 3403 - 3411.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Marques, A. Kumar, I. Cortes, A. Gonzalez-Garcia, C. Hernandez, M. C. Moreno-Ortiz, and A. C. Carrera
Phosphoinositide 3-Kinases p110{alpha} and p110{beta} Regulate Cell Cycle Entry, Exhibiting Distinct Activation Kinetics in G1 Phase
Mol. Cell. Biol., April 15, 2008; 28(8): 2803 - 2814.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
F. Li, P. S. Pallan, M. A. Maier, K. G. Rajeev, S. L. Mathieu, C. Kreutz, Y. Fan, J. Sanghvi, R. Micura, E. Rozners, et al.
Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme
Nucleic Acids Res., October 8, 2007; 35(19): 6424 - 6438.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. S. Gondi, S. S. Lakka, D. H. Dinh, W. C. Olivero, M. Gujrati, and J. S. Rao
Intraperitoneal Injection of a Hairpin RNA Expressing Plasmid Targeting Urokinase-Type Plasminogen Activator (uPA) Receptor and uPA Retards Angiogenesis and Inhibits Intracranial Tumor Growth in Nude Mice
Clin. Cancer Res., July 15, 2007; 13(14): 4051 - 4060.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L. Heron-Milhavet, C. Franckhauser, V. Rana, C. Berthenet, D. Fisher, B. A. Hemmings, A. Fernandez, and N. J. C. Lamb
Only Akt1 Is Required for Proliferation, while Akt2 Promotes Cell Cycle Exit through p21 Binding
Mol. Cell. Biol., November 15, 2006; 26(22): 8267 - 8280.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Liu, Y. Shi, M. J. Birnbaum, K. Ye, R. De Jong, T. Oltersdorf, V. L. Giranda, and Y. Luo
Quantitative Analysis of Anti-apoptotic Function of Akt in Akt1 and Akt2 Double Knock-out Mouse Embryonic Fibroblast Cells under Normal and Stressed Conditions
J. Biol. Chem., October 20, 2006; 281(42): 31380 - 31388.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S.-i. Yaguchi, Y. Fukui, I. Koshimizu, H. Yoshimi, T. Matsuno, H. Gouda, S. Hirono, K. Yamazaki, and T. Yamori
Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.
J Natl Cancer Inst, April 19, 2006; 98(8): 545 - 556.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Kang, A. Denley, B. Vanhaesebroeck, and P. K. Vogt
Oncogenic transformation induced by the p110beta, -{gamma}, and -{delta} isoforms of class I phosphoinositide 3-kinase
PNAS, January 31, 2006; 103(5): 1289 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
D. Tondera, F. Czauderna, K. Paulick, R. Schwarzer, J. Kaufmann, and A. Santel
The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells
J. Cell Sci., July 15, 2005; 118(14): 3049 - 3059.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
P. WORKMAN
Drugging the Cancer Kinome: Progress and Challenges in Developing Personalized Molecular Cancer Therapeutics
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 499 - 515.
[Abstract] [PDF]

Home page
 Mol. Endocrinol.Home page
A.-M. Gaben, C. Saucier, M. Bedin, G. Redeuilh, and J. Mester
Mitogenic Activity of Estrogens in Human Breast Cancer Cells Does Not Rely on Direct Induction of Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase or Phosphatidylinositol 3-Kinase
Mol. Endocrinol., November 1, 2004; 18(11): 2700 - 2713.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. D. Buckingham, B. Esmaeili, M. Wood, and D. B. Sattelle
RNA interference: from model organisms towards therapy for neural and neuromuscular disorders
Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R275 - R288.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Tondera, A. Santel, R. Schwarzer, S. Dames, K. Giese, A. Klippel, and J. Kaufmann
Knockdown of MTP18, a Novel Phosphatidylinositol 3-Kinase-dependent Protein, Affects Mitochondrial Morphology and Induces Apoptosis
J. Biol. Chem., July 23, 2004; 279(30): 31544 - 31555.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. S. Roberts, A. J. Woods, T. C. Dale, P. van der Sluijs, and J. C. Norman
Protein Kinase B/Akt Acts via Glycogen Synthase Kinase 3 To Regulate Recycling of {alpha}v{beta}3 and {alpha}5{beta}1 Integrins
Mol. Cell. Biol., February 15, 2004; 24(4): 1505 - 1515.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. E. Barbieri, C. E. Barton, and J. A. Pietenpol
{Delta}Np63{alpha} Expression Is Regulated by the Phosphoinositide 3-Kinase Pathway
J. Biol. Chem., December 19, 2003; 278(51): 51408 - 51414.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
O. Milhavet, D. S. Gary, and M. P. Mattson
RNA Interference in Biology and Medicine
Pharmacol. Rev., December 1, 2003; 55(4): 629 - 648.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
F. Czauderna, A. Santel, M. Hinz, M. Fechtner, B. Durieux, G. Fisch, F. Leenders, W. Arnold, K. Giese, A. Klippel, et al.
Inducible shRNA expression for application in a prostate cancer mouse model
Nucleic Acids Res., November 1, 2003; 31(21): e127 - e127.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
F. Czauderna, M. Fechtner, S. Dames, H. Aygun, A. Klippel, G. J. Pronk, K. Giese, and J. Kaufmann
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells
Nucleic Acids Res., June 1, 2003; 31(11): 2705 - 2716.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.